Measurement and genetic architecture of lifetime depression in the Netherlands as assessed by LIDAS (Lifetime Depression Assessment Self-report)
Title | Measurement and genetic architecture of lifetime depression in the Netherlands as assessed by LIDAS (Lifetime Depression Assessment Self-report) |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Fedko, IO, Hottenga, J-J, Helmer, Q, Mbarek, H, Huider, F, Amin, N, Beulens, JW, Bremmer, MA, Elders, PJ, Galesloot, TE, Kiemeney, LA, van Loo, HM, H Picavet, SJ, Rutters, F, van der Spek, A, van de Wiel, AM, van Duijn, C, de Geus, EJC, Feskens, EJM, Hartman, CA, Oldehinkel, AJ, Smit, JH, Verschuren, WMMonique, Penninx, BWJH, Boomsma, DI, Bot, M |
Journal | Psychological Medicine |
Volume | 51 |
Pagination | 1–10 |
Keywords | LIDAS, Lifetime Depression Assessment Self-report, major depressive disorder, online assessment tool, prevalence |
Abstract | BACKGROUND: Major depressive disorder (MDD) is a common mood disorder, with a heritability of around 34%. Molecular genetic studies made significant progress and identified genetic markers associated with the risk of MDD; however, progress is slowed down by substantial heterogeneity as MDD is assessed differently across international cohorts. Here, we used a standardized online approach to measure MDD in multiple cohorts in the Netherlands and evaluated whether this approach can be used in epidemiological and genetic association studies of depression. METHODS: Within the Biobank Netherlands Internet Collaboration (BIONIC) project, we collected MDD data in eight cohorts involving 31 936 participants, using the online Lifetime Depression Assessment Self-report (LIDAS), and estimated the prevalence of current and lifetime MDD in 22 623 unrelated individuals. In a large Netherlands Twin Register (NTR) twin-family dataset (n $\approx$ 18 000), we estimated the heritability of MDD, and the prediction of MDD in a subset (n = 4782) through Polygenic Risk Score (PRS). RESULTS: Estimates of current and lifetime MDD prevalence were 6.7% and 18.1%, respectively, in line with population estimates based on validated psychiatric interviews. In the NTR heritability estimates were 0.34/0.30 (s.e. = 0.02/0.02) for current/lifetime MDD, respectively, showing that the LIDAS gives similar heritability rates for MDD as reported in the literature. The PRS predicted risk of MDD (OR 1.23, 95% CI 1.15-1.3 |
DOI | 10.1017/S0033291720000100 |